Case number 1:18-cv-00090
H. Lundbeck A/S et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 29, 2021 | 21 | Patent/Trademark Report to Commissioner (10) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Oct 29, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 1090 in lead case no. 18-88-LPS) (ntl) |
| Jan 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb) |
| Jan 10, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak) |
| Sep 4, 2018 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.s Supplemental Initial Disclosures pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) |
| Jul 9, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl) |
| Jul 3, 2018 | 19 | Letter to The Honorable Leonard P. Stark (1) |
| Jul 3, 2018 | 19 | Main Document (22) Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack) |
| Jun 19, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 12, 2018 | 18 | Main Document (23) Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 12, 2018 | 18 | Cover Letter (1) |
| Jun 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Jun 6, 2018 | 17 | Stipulation to EXTEND Time (14) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack) |
| May 23, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Court will hold a Case Management Conference in courtroom 6B on June 19, 2018 at 9:00 a.m. In preparation for the CMC, counsel shall meet and confer and address the items listed in the "Checklist," and submit a proposed scheduling order no later than June 6, 2018. ORDERED by Judge Leonard P. Stark on 5/23/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| May 2, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Stephanie M. Roberts, Lance Sodertrom, Deepro R. Mukerjee, and Joseph M. Janusz filed by Lupin Limited, Lupin Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 5/2/18. (ntl) |
| Apr 30, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephanie M. Roberts, Lance Sodertrom, Deepro R. Mukerjee, and Joseph M. Janusz - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) |
| Apr 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:18-cv-00147-LPS, 19 in 1:18-cv-00148-LPS, 12 in 1:18-cv-00177-LPS, 14 in 1:18-cv-00149-LPS, 14 in 1:18-cv-00090-LPS, 17 in 1:18-cv-00150-LPS, 18 in 1:18-cv-00176-LPS, 11 in 1:18-cv-00092-LPS, 16 in 1:18-cv-00114-LPS, 19 in 1:18-cv-00113-LPS, 18 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00175-LPS, 16 in 1:18-cv-00091-LPS) MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 4/26/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl) |
| Apr 25, 2018 | 14 | Motion for Leave to Appear Pro Hac Vice (19) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda of Covington & Burling LLP - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Dellinger, Megan) |
| Apr 12, 2018 | 13 | Answer to Counterclaim (18) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack) |
| Mar 22, 2018 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Limited.(Lennon, James) |
| Mar 22, 2018 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited, Other Affiliate Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) |
| Feb 1, 2018 | 7 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Lupin Limited on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Lupin Limited waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 9 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Lupin Pharmaceuticals, Inc. on 1/31/2018 by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. Waiver of Service due by 3/5/2018. (Noreika, Maryellen) |
| Feb 1, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.: For Lupin Pharmaceuticals, Inc. waiver sent on 1/31/2018, answer due 4/2/2018. (Noreika, Maryellen) |
| Jan 17, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00088-LPS, 1:18-cv-00089-LPS, 1:18-cv-00090-LPS, 1:18-cv-00091-LPS, 1:18-cv-00092-LPS (rjb) |
| Jan 12, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 1/12/2018; Lupin Pharmaceuticals, Inc. on 1/12/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Jan 12, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Corporate Parent Takeda Pharma A/S, Corporate Parent Takeda Europe Holdings B.V., Corporate Parent Takeda A/S for Takeda Pharmaceuticals International AG filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (nmfn) |
| Jan 12, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (nmfn) |
| Jan 12, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2; 8,969,355 B2; 9,227,946 B2. (nmfn) |
| Jan 12, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/1/2017. Date of Expiration of Patent: 6/15/2027 for U.S. Patent Nos. 8,969,355 and 9,227,946. Date of Expiration of Patent for U.S. Patent No. 8,722,684 is 6/30/2031. Thirty Month Stay Deadline: 3/30/2021. (nmfn) |
| Jan 12, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Jan 12, 2018 | 1 | Civil Cover Sheet (2) |
| Jan 12, 2018 | 1 | Exhibits A-C (144) |
| Jan 12, 2018 | 1 | Main Document (19) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2300423.) - filed by H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd.. (Attachments: # (1) Exhibits A-C, # (2) Civil Cover Sheet)(nmfn) |
| Jan 12, 2018 | 1 | Complaint* (1) |
